Device / Technology News

RSS
Lucideon and ReBioStent project partners to host Bioresorbable Materials for Medical Applications session at ESB 2015

Lucideon and ReBioStent project partners to host Bioresorbable Materials for Medical Applications session at ESB 2015

Implanted biochemical sensor could allow doctors to better monitor, adjust cancer treatments

Implanted biochemical sensor could allow doctors to better monitor, adjust cancer treatments

New partnership aims to provide high-tech healthcare learning opportunities for pediatric patients

New partnership aims to provide high-tech healthcare learning opportunities for pediatric patients

Amedica’s four scientific presentations to highlight benefits of silicon nitride platform at ISTA

Amedica’s four scientific presentations to highlight benefits of silicon nitride platform at ISTA

Armada, UMass Medical School partner to enhance ArmadaOne Specialty Pharmacy Workflow Platform

Armada, UMass Medical School partner to enhance ArmadaOne Specialty Pharmacy Workflow Platform

Cardiac Science announces sale of 25 Powerheart G5 AEDs to Lippert Components

Cardiac Science announces sale of 25 Powerheart G5 AEDs to Lippert Components

Netsync Network Solutions achieves Telehealth Authorized Technology Provider status from Cisco

Netsync Network Solutions achieves Telehealth Authorized Technology Provider status from Cisco

Laser autofocus option added to BioTek’s Cytation Cell Imaging Multi-Mode Readers

Laser autofocus option added to BioTek’s Cytation Cell Imaging Multi-Mode Readers

Study identifies factors that contribute to government transparency

Study identifies factors that contribute to government transparency

SGI-DNA recognized by Frost & Sullivan for BioXp 3200 System

SGI-DNA recognized by Frost & Sullivan for BioXp 3200 System

G7 Therapeutics, MorphoSys collaborate on novel antibody therapeutics targeting GPCRs and ion channels

G7 Therapeutics, MorphoSys collaborate on novel antibody therapeutics targeting GPCRs and ion channels

Imperial Innovations announces launch of pre-clinical spinout company, Orthonika

Imperial Innovations announces launch of pre-clinical spinout company, Orthonika

Stress Resilience Training System app for military personnel now available through Apple App Store

Stress Resilience Training System app for military personnel now available through Apple App Store

Northwestern gets $17.5 million NIH grant to invent, develop implantable drug delivery system for HIV prevention

Northwestern gets $17.5 million NIH grant to invent, develop implantable drug delivery system for HIV prevention

NYSCF scientists design new robotic platform to automate generation of patient-specific stem cells

NYSCF scientists design new robotic platform to automate generation of patient-specific stem cells

First biodegradable gene delivery system efficiently penetrates human airway mucus barrier of lung tissue

First biodegradable gene delivery system efficiently penetrates human airway mucus barrier of lung tissue

Scientists develop artificial blood vessels that are resistant to blood clot formation

Scientists develop artificial blood vessels that are resistant to blood clot formation

Scientists successfully test new tumor diagnosis method

Scientists successfully test new tumor diagnosis method

Exalenz Bioscience, Galectin Therapeutics to use BreathID test to assess GR-MD-O2 efficacy in NASH Cirrhosis patients

Exalenz Bioscience, Galectin Therapeutics to use BreathID test to assess GR-MD-O2 efficacy in NASH Cirrhosis patients

Physically impaired people to compete at Cybathlon 2016

Physically impaired people to compete at Cybathlon 2016

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.